Arbutus Biopharma (ABUS) Long-Term Investments (2014 - 2024)
Arbutus Biopharma (ABUS) reported Long-Term Investments of $2.96 million for Q3 2024, down 71.8% from $10.5 million a year earlier and down 54.6% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Long-Term Investments (2014 - 2024) Analysis & Trends
At the end of FY2023, Arbutus Biopharma posted Long-Term Investments of $6.28 million, down 83.2% from FY2022.
- Long-Term Investments has a five-year compound annual growth rate of -22.3% (FY2018 to FY2023).
- By year, Long-Term Investments came in at $37.36 million in FY2022 (+4.7%) and $35.69 million in FY2021.
- The Q3 2024 figure ranks as the lowest quarterly Long-Term Investments since Q2 2020.
- Year over year, Long-Term Investments has now declined in each of the last seven quarters, with an average decline of 58.3% over the last eight quarters.
- The high point for year-over-year Long-Term Investments in five years was Q3 2022 (growth of 81.6%); the low point was Q2 2020 (a decline of 88.9%).
- Per Business Quant data, the three quarters before Q3 2024 came in at $6.53 million (Q2 2024), $8.68 million (Q1 2024) and $6.28 million (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Arbutus Biopharma | 944.69 Mn | 571.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 2.96 Mn |
| Jun 30, 2024 | 6.53 Mn |
| Mar 31, 2024 | 8.68 Mn |
| Dec 31, 2023 | 6.28 Mn |
| Sep 30, 2023 | 10.50 Mn |
| Jun 30, 2023 | 11.06 Mn |
| Mar 31, 2023 | 31.79 Mn |
| Dec 31, 2022 | 37.36 Mn |
| Sep 30, 2022 | 55.44 Mn |
| Jun 30, 2022 | 50.45 Mn |
| Mar 31, 2022 | 56.32 Mn |
| Dec 31, 2021 | 35.69 Mn |
| Sep 30, 2021 | 30.53 Mn |
| Jun 30, 2021 | 35.69 Mn |
| Mar 31, 2021 | 35.69 Mn |
| Jun 30, 2020 | 1.60 Mn |
| Mar 31, 2020 | 3.22 Mn |
| Sep 30, 2019 | 10.97 Mn |
| Jun 30, 2019 | 14.38 Mn |
| Mar 31, 2019 | 17.68 Mn |
API Access
Arbutus Biopharma Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();